Cargando…
Author Correction: The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas
Autores principales: | Li, Kai, Ma, Lei, Sun, Ye, Li, Xiang, Ren, Hong, Tang, Shou-Ching, Sun, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393970/ https://www.ncbi.nlm.nih.gov/pubmed/37528138 http://dx.doi.org/10.1038/s41598-023-39545-0 |
Ejemplares similares
-
The immunotherapy candidate TNFSF4 may help the induction of a promising immunological response in breast carcinomas
por: Li, Kai, et al.
Publicado: (2021) -
Author Correction: Microphysiological model reveals the promise of memory-like natural killer cell immunotherapy for HIV(±) cancer
por: Ayuso, Jose M., et al.
Publicado: (2023) -
TNFSF14: LIGHTing the Way for Effective Cancer Immunotherapy
por: Skeate, Joseph G., et al.
Publicado: (2020) -
Associations between TNFSF4, TNFSF8 and TNFSF15 and Behçet's disease but not VKH syndrome in Han Chinese
por: Jiang, Yan, et al.
Publicado: (2017) -
Comprehensive characterization of TNFSF14/LIGHT with implications in prognosis and immunotherapy of human gliomas
por: Han, Mingzhi, et al.
Publicado: (2022)